Research and Markets ( has announced the addition of “Shire – Company Profile” to their offering.

Company Profile will assists individual investors, managers and companies in evaluating opportunities, trends, market innovations, and selecting appropriate information solutions in order to make effective decisions. The report has been made after extensive research using the data available from reliable publications, trade associations and the companies’ sources.

The report elaborates on the company’s business structure and operations, products and services. The report includes key financial information and strategic analysis that intends to aid investors to find better prospects with the company and gain an insight into the corporate policies.

Report Highlights

  • Provides a snapshot version of the company’s performance, through its financials and charts to evaluate the company growth trends.
  • It offers key company data and analysis vis-à-vis to the major industry players. This information is vital from the point of estimating business strategies of the company and facilitate in decision-making process for the investors.
  • Provides key financial information of the company, sales and product ratio, revenue and income trend, stock performances for the most recently ended quarter, financial year across businesses, and product/service categories.
  • Tracks major M&A trends and developments undertaken in the current fiscal year to get a better understanding of company’s growth strategies.
  • The report identifies and analyzes the company’s strength and weaknesses to come up with the possible opportunities for the company.
  • The report comments on the company’s outlook for the forthcoming periods both on strategic and financial point of views.
  • Supplemented with graphs and tabular information on the key industry players, overall financial and market performances, list of products and services, and company’s share performances.

Topics Covered:

  • Abbott Laboratories
  • Novo Nordisk A/S
  • Novartis AG
  • Eli Lilly & CO.
  • Pfizer Inc.

For more information, visit

Research and Markets
Laura Wood,
fax: +353 1 4100 980